Delivery Order SPE2DB24D2205-SPE2DB25FEFVW
- Not listed
- The U.S. Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order to Amerisourcebergen Drug Corp, a leading global pharmaceutical distributor, to provide 4,563,628,875 units of Tamsulosin HCl 0.4 mg capsules. The $3,049.48 order has a completion date of February 13, 2024. Amerisourcebergen Drug Corp, through its Corporate Office division based in Conshohocken, Pennsylvania, is the prime contractor. This delivery order is part of a larger indefinite...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules, with a contract ceiling value of $1,727.65. This is a firm fixed-price delivery order with no set-aside designation, performed at the contractor's corporate office location in Conshohocken, Pennsylvania, and scheduled for completion by August 8, 2025. The award represents a routine pharmaceutical supply transaction supporting...
- The Defense Logistics Agency awarded a $4,573.03 delivery order to AmerisourceBergen Drug Corp for 1,000 capsules of Tamsulosin HCL 0.4 mg, with a completion date of July 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and is classified as a child award under a larger contract vehicle. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg, a common medication used to treat benign prostatic hyperplasia. This firm fixed-price delivery order, valued at $11,771.03, is scheduled for completion by August 14, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award was made through competitive procedures with no...
- The Defense Logistics Agency awarded a delivery order valued at $2,609.16 to AmerisourceBergen Drug Corp for 1,000 capsules of Tamsulosin HCL 0.4 mg, with delivery expected by July 31, 2025. This non-set-aside, competitively awarded contract utilizes firm fixed pricing and represents a small-value pharmaceutical procurement supporting military healthcare supply needs. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of 1,000 units of Tamsulosin HCL 0.4 mg capsules, valued at $10,368.01. This is a firm fixed-price delivery order with an ultimate completion date of August 11, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract was awarded competitively with no set-aside designation. This delivery order is issued under...
- The U.S. Defense Logistics Agency (DLA) awarded a firm-fixed-price delivery order contract valued at $1,691.07 to Amerisourcebergen Drug Corp's Corporate Office Division for the supply of 4,565,111,422 units of Tamsulosin HCL 0.4 mg capsules. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999.00 that Amerisourcebergen holds with DLA Troop Support Medical, which serves as the primary vehicle for the company to provide a wide range of pharmaceutical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg at a ceiling value of $2,520.50. This is a firm fixed price delivery order with an ultimate completion date of August 11, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The contract was competitively awarded with no set-aside designation, reflecting open competition among qualified pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $1,613.70 to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of 1,000 capsules of Tamsulosin HCL 0.4 mg. This contract employs a firm fixed price delivery order structure with no set-aside designation, indicating competitive award. The pharmaceutical product will be supplied to the place of performance in Conshohocken, Pennsylvania, with an ultimate completion date of August 18, 2025. This delivery order is issued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,530.81 firm fixed-price delivery order is for the supply of 4,562,264,266 Tamsulosin HCl 0.4 mg capsules. The contract has an ultimate completion date of September 22, 2023. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- SPE2DB24D2205Indefinite Delivery Contract
- SPE2DB24D2205-SPE2DB25FEFVWDelivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $3,738.42 on August 5, 2025, for the supply of Tamsulosin HCL 0.4 mg capsules (1,000 count). This award is non-competitive and carries a firm fixed price structure with completion targeted for August 6, 2025. The order will be fulfilled from AmerisourceBergen's facility in Conshohocken, Pennsylvania, where the company maintains its corporate headquarters. This delivery order is issued under a larger contract vehicle and represents a routine pharmaceutical procurement supporting federal medical supply chain requirements. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, holds an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued at $999,999,999 through December 2026, designated SPE2DX. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the company to supply a broad range of medications, vaccines, and medical supplies to military healthcare programs and other federal agencies including the Defense Health Agency and U.S. Coast Guard. The current delivery order represents one of numerous execution orders issued against this substantial contract vehicle, demonstrating AmerisourceBergen's established role as a critical pharmaceutical supplier within the federal medical procurement ecosystem.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.7k | 8/5/25 |